Publications by authors named "B V Becker"

Individuals often actively suppress intrusive memories to alleviate the distress they cause and maintain mental well-being. However, those with post-traumatic stress disorder (PTSD) often exhibit difficulties particularly in inhibiting or suppressing negative memories compared to individuals without PTSD. These memories can involve a physical threat either to the individual themselves or to others.

View Article and Find Full Text PDF

Biological soil crusts are integral to Arctic ecosystems, playing a crucial role in primary production, nitrogen fixation and nutrient cycling, as well as maintaining soil stability. However, the composition and complex relationships between the diverse organisms within these biocrusts are not well studied. This study investigates how the microbial community composition within Arctic biocrusts is influenced by environmental factors along an altitudinal gradient (101 m to 314 m).

View Article and Find Full Text PDF

Background: The lack of clearly defined neuromodulation targets has contributed to the inconsistent results of real-time fMRI-based neurofeedback (rt-fMRI-NF) for the treatment of chronic pain. Functional neurosurgery (funcSurg) approaches have shown more consistent effects in reducing pain in patients with severe chronic pain.

Objective: This study aims to redefine rt-fMRI-NF targets for chronic pain management informed by funcSurg studies.

View Article and Find Full Text PDF

Background: Sudden cardiac death (SCD) is generally associated with life-threatening ventricular arrhythmias. Supraventricular arrhythmias are an accepted cause of SCD in Wolff-Parkinson-White syndrome and complex congenital heart disease. However, the role of atrial tachyarrhythmias (ATAs) in SCD in patients with structurally normal hearts is unclear.

View Article and Find Full Text PDF
Article Synopsis
  • - Deucravacitinib is a new oral medication approved in Japan for treating different types of psoriasis, including plaque, generalized pustular, and erythrodermic psoriasis.
  • - The POETYK PSO-4 clinical trial involving 74 Japanese patients showed that the drug was effective and well tolerated, with significant improvements in psoriasis symptoms and quality of life over 52 weeks.
  • - Results indicated that about two-thirds of patients achieved a Dermatology Life Quality Index score of 0 or 1 by week 52, although the small number of participants with generalized pustular or erythrodermic psoriasis makes it harder to draw broad conclusions for these types.
View Article and Find Full Text PDF